Aspects of haemophilia prophylaxis in Sweden

被引:12
作者
Ljung, RCR [1 ]
机构
[1] Lund Univ, Univ Hosp, Paediat Clin, Dept Paediat, SE-20502 Malmo, Sweden
[2] Lund Univ, Univ Hosp, Dept Coagulat Disorders, Malmo, Sweden
关键词
haemophilia A; haemophilia B; factor VIII; factor IX;
D O I
10.1046/j.1351-8216.2001.00118.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Prophylactic treatment of haemophilia has been gaining acceptance as the optimal therapeutic option in an increasing number of haemophilia centres in the developed world in recent years. This paper focus on three aspects of prophylactic therapy: when to start treatment, venous access and the dose/dose interval. Evidence is in favour of prophylactic treatment to be started at an early age using either a peripheral vein with 1-2 injections per week and a successive increase in the frequency depending on the child and the veins, or, using a Port-A-Cath which allows a better prophylactic coverage by infusions preferably every second day in haemophilia A and every third day in haemophilia B.
引用
收藏
页码:34 / 37
页数:4
相关论文
共 19 条
[1]   A LONGITUDINAL-STUDY OF ORTHOPEDIC OUTCOMES FOR SEVERE FACTOR-VIII-DEFICIENT HEMOPHILIACS [J].
ALEDORT, LM ;
HASCHMEYER, RH ;
PETTERSSON, H ;
EIBL, H ;
GILBERT, M ;
HILGARTNER, M ;
KUNSHACK, M ;
LARRIEU, MJ ;
LEVINE, P .
JOURNAL OF INTERNAL MEDICINE, 1994, 236 (04) :391-399
[2]   Primary prophylaxis in severe haemophilia should be started at an early age but can be individualized [J].
Astermark, J ;
Petrini, P ;
Tengborn, L ;
Schulman, S ;
Ljung, R ;
Berntorp, E .
BRITISH JOURNAL OF HAEMATOLOGY, 1999, 105 (04) :1109-1113
[3]   METHODS OF HEMOPHILIA CARE DELIVERY - REGULAR PROPHYLAXIS VERSUS EPISODIC TREATMENT [J].
BERNTORP, E .
HAEMOPHILIA, 1995, 1 :3-7
[4]  
Blanchette VS, 1997, BLOOD COAGUL FIBRIN, V8, pS11
[5]   HEMOPHILIA PROPHYLAXIS WITH FACTOR-VIII CONCENTRATE [J].
KASPER, CK ;
DIETRICH, SL ;
RAPAPORT, SI .
ARCHIVES OF INTERNAL MEDICINE, 1970, 125 (06) :1004-&
[6]  
Knobe KE, 1999, HAEMOPHILIA, V5, P238
[7]   When should prophylactic treatment in patients with haemophilia A and B start? - The German experience [J].
Kreuz, W ;
Escuriola-Ettingshausen, C ;
Funk, M ;
Schmidt, H ;
Kornhuber, B .
HAEMOPHILIA, 1998, 4 (04) :413-417
[8]   The impact of prophylactic treatment on children with severe haemophilia [J].
Liesner, RJ ;
Khair, K ;
Hann, IM .
BRITISH JOURNAL OF HAEMATOLOGY, 1996, 92 (04) :973-978
[9]   Port-A-Cath usage in children with haemophilia:: experience of 53 cases [J].
Ljung, R ;
van den Berg, M ;
Petrini, P ;
Tengborn, L ;
Scheibel, E ;
Kekomäki, R ;
Effenberger, W .
ACTA PAEDIATRICA, 1998, 87 (10) :1051-1054
[10]   IMPLANTABLE CENTRAL VENOUS CATHETER FACILITATES PROPHYLACTIC TREATMENT IN CHILDREN WITH HEMOPHILIA [J].
LJUNG, R ;
PETRINI, P ;
LINDGREN, AK ;
BERNTORP, E .
ACTA PAEDIATRICA, 1992, 81 (11) :918-920